Drug Shortages And Its Effects On Health Care Delivery Models

1709 Words Dec 3rd, 2015 null Page
Shortages in sterile injectable drug availability are not new and have gathered increasing attention since the early 2000’s. Their impact has gained particular significance due to healthcare reforms that have impacted reimbursement criteria and health care delivery models. These shortages have caused significant impact in the hospital setting not only in quality and safety concerns, but in financial planning as well. In 2011 a report indicated that drug shortages cost US providers at least $200 Million annually. In addition it caused safety risks due to the introduction and administration of unfamiliar drugs. The costs of drugs have increased an average of 11% (Drug Shortages, 2011): this does not include the increased cost of gray market drug purchases which can be substantial, for some drugs exceeding 4000% (AHA, 2011; May, 2011). The “gray market” refers to the trade of a commodity, in this case pharmaceuticals, through distribution networks that are legal but are not intended by the manufacturer.
The drug shortage crisis peaked in 2011. A report by the American Society of Health-System Pharmacists (ASHP) indicated that in addition to the increased cost of drugs themselves, the increased labor costs associated with managing these shortages cost an additional 216 million dollars (Rubenfire, 2015). In 2012 82% of hospitals reported delaying treatment due to lack of drug availability, 99.5% stated they had experienced a drug shortage in the last 6 months,…

Related Documents